Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
| Autor: | Sung-Jung Ho, Ming-Han Tsai, Lit-Min Wu, Pu-Sheng Yeh, Tzu-Yi Chuang, Yi-Lien Liu, Hung-Jen Fred Yang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Microbiology (medical)
ARDS 2019-20 coronavirus outbreak medicine.medical_specialty Coronavirus disease 2019 (COVID-19) General Immunology and Microbiology business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lcsh:QR1-502 General Medicine medicine.disease lcsh:Microbiology chemistry.chemical_compound Ivermectin Tocilizumab Infectious Diseases chemistry Internal medicine Correspondence Medicine Immunology and Allergy business medicine.drug |
| Zdroj: | Journal of Microbiology, Immunology, and Infection Journal of Microbiology, Immunology and Infection Journal of Microbiology, Immunology and Infection, Vol 54, Iss 1, Pp 147-148 (2021) |
| ISSN: | 1995-9133 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|